Search

Your search keyword '"Ortolani, P."' showing total 50 results

Search Constraints

Start Over You searched for: Author "Ortolani, P." Remove constraint Author: "Ortolani, P." Topic humans Remove constraint Topic: humans
50 results on '"Ortolani, P."'

Search Results

1. Screening for atrial fibrillation in the general population: experience from a cardiovascular risk campaign in the Emilia-Romagna Region|Screening della fibrillazione atriale nella popolazione generale: esperienza della campagna educazionale sul rischio cardiovascolare della Regione Emilia-Romagna

2. Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients

3. Amniocentesis and chorionic villus sampling in HIV-infected pregnant women: a multicentre case series

4. Incidence of Malignancies in HIV‐Infected Patients and Prognostic Role of Current CD4 Cell Count: Evidence from a Large Italian Cohort Study

5. Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona Foundation study

6. Clinical Features of Bacterial Meningitis in Italy: a Multicenter Prospective Observational Study

7. Good prenatal detection rate of major birth defects in HIV-infected pregnant women in Italy

8. Genotypic resistance profiles associated with virological failure to darunavir-containing regimens: a cross-sectional analysis

9. Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort

10. Favourable evolution of virological and immunological profiles in treated and untreated patients in Italy in the period 1998-2008

11. No pol mutation is associated independently with the lack of immune recovery in patients infected with HIV and failing antiretroviral therapy

12. Clinical presentation and outcome of colorectal cancer in HIV-positive patients: a clinical case-control study

13. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy : not all AIDS-defining conditions are created equal

14. Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study

15. Body Mass Index and Weight Gain in Pregnant Women With HIV: A National Study in Italy

16. Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011

17. A novel methodology for large-scale phylogeny partition

18. Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study

19. Importance of baseline prognostic factors with increasing time since initiation of highly active antiretroviral therapy: collaborative analysis of cohorts of HIV-1-infected patients

20. Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: The Istituto Superiore di Sanità-Pulsed Antiretroviral Therapy (ISS-PART) study

21. Economic evaluation of HIV treatments: The I.CO.N.A. cohort study

22. A Prognostic Model for Estimating the Time to Virologic Failure in HIV-1 Infected Patients Undergoing a New Combination Antiretroviral Therapy Regimen

23. Virologic and immunologic response to regimens containing nevirapine or efavirenz in combination with 2 nucleoside analogues in the Italian Cohort Naive Antiretrovirals (I.Co.N.A.) study

24. [Role of transesophageal echography in the diagnosis of aortic dissection and in therapy programming]

25. Clinical relevance of homocysteine levels in patients receiving coronary stenting for unstable angina

26. Genetic and Functional Characterization of Toll-Like Receptor Responses in Immunocompetent Patients With CMV Mononucleosis

27. Reactive follicular lymphoid infiltrate: A new condition to exclude in patients with PET positivity inside the heart

28. How many patients with severe symptomatic aortic stenosis excluded for cardiac surgery are eligible for transcatheter heart valve implantation?

29. Long-term effectiveness of early administration of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: results of a registry study in an ST-elevation myocardial infarction network

30. Comparison Between Coronary Angioplasty and Coronary Artery Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Stenosis (the Bologna Registry)

31. Clinical impact of direct referral to primary percutaneous coronary intervention following pre-hospital diagnosis of ST-elevation myocardial infarction

32. Clinical imaging of the vulnerable plaque in the coronary arteries: new intracoronary diagnostic methods

33. Recent temporal trends for first-time hospitalization for acute myocardial infarction. Treatment patterns and clinical outcome in a large cohort study

34. What is the acceptable rate of false positives for STEMI within a primary PCI network? Insights from a metropolitan system with direct ambulance-based access

35. One-year clinical outcome in patients with acute coronary syndrome treated with concomitant use of clopidogrel and proton pump inhibitors: results from a regional cohort study

36. Impact of a territorial ST-segment elevation myocardial infarction network on prognosis of patients with out-of-hospital cardiac arrest

37. Short- and long-term prognostic significance of ST-segment elevation in lead aVR in patients with non-ST-segment elevation acute coronary syndrome

38. Safety and efficacy of early aggressive versus cholesterol-driven lipid-lowering strategies in heart transplantation: A pilot, randomized, intravascular ultrasound study

39. Prognostic significance of mean platelet volume on admission in an unselected cohort of patients with non ST-segment elevation acute coronary syndrome

40. Lower long-term mortality within a regional system of care for ST-elevation myocardial infarction

41. A randomised study comparing the antiplatelet and antiinflammatory effect of clopidogrel 150 mg/day versus 75 mg/day in patients with ST-segment elevation acute myocardial infarction and poor responsiveness to clopidogrel: results from the DOUBLE study

42. Optimisation of therapeutic strategies for ST-segment elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality

43. Prophylaxis versus preemptive anti-cytomegalovirus approach for prevention of allograft vasculopathy in heart transplant recipients

44. Usefulness of prehospital triage in patients with cardiogenic shock complicating ST-elevation myocardial infarction treated with primary percutaneous coronary intervention

45. Randomized comparative trial of a thin-strut bare metal cobalt-chromium stent versus a sirolimus-eluting stent for coronary revascularization

46. Clinical comparison of 'normal-hours' vs 'off-hours' percutaneous coronary interventions for ST-elevation myocardial infarction

47. 32P brachytherapy in the treatment of complex Cypher in-stent restenosis

48. Preprocedural Levels of C-Reactive Protein and Leukocyte Counts Predict 9-Month Mortality After Coronary Angioplasty for the Treatment of Unprotected Left Main Coronary Artery Stenosis

49. Long-term clinical and angiographic outcome of patients with occlusive in-stent restenosis treated with (32P) beta-brachytherapy

50. Predictors of trend in CD4-positive T-cell count and mortality among HIV-1 infected individuals with virological failure to all three antiretroviral-drug classes

Catalog

Books, media, physical & digital resources